(Q45778284)

English

Current status of development of anticancer agents in Japan

scientific article published on 29 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Current status of development of anticancer agents in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

corrigendum / erratum

Erratum to: Current status of development of anticancer agents in Japan.

0 references

author name string

Tomohiro Morita

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Akiko Hori

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Hiroto Narimatsu

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Tetsuya Tanimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Masahiro Kami

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

publication date

29 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

87

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

484-489

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

https://scigraph.springernature.com/pub.10.1007/s12185-008-0087-2

0 references

[Review process of anticancer drugs in Japan]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reimbursement for cancer treatment: coverage of off-label drug indications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncology drug clinical development and approval in Japan: the role of the pharmaceuticals and medical devices evaluation center (PMDEC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unconventional anticancer agents: a systematic review of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib: delivering a targeted drug to the right targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging drugs for non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18443741

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-008-0087-2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/18443741

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45778284&oldid=2082289654"